<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Granulocytic <z:hpo ids='HP_0100242'>sarcomas</z:hpo> (GS) are rare extramedullary <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> masses composed of immature cells derived from the hematopoietic myeloid series </plain></SENT>
<SENT sid="1" pm="."><plain>GS occur in 3% to 7% of cases of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and can present before, during, or even after the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>GS can involve different organs, individually or simultaneously, including the skin, lymph nodes, bone, breast, central <z:mp ids='MP_0008912'>nervous</z:mp> system, and lung among others </plain></SENT>
<SENT sid="3" pm="."><plain>GS involving peritoneal and pleural fluids is a rare presentation </plain></SENT>
<SENT sid="4" pm="."><plain>We present an unusual case of a patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> whose disease progressed into a <z:e sem="disease" ids="C0280449" disease_type="Neoplastic Process" abbrv="">secondary AML</z:e> and developed GS in the ascitic and <z:hpo ids='HP_0002202'>pleural effusions</z:hpo> as the predominant manifestation of disease progression </plain></SENT>
</text></document>